Enzyme‐Functionalized Microparticles to Open the Vitreoretinal Interface
Small · 09.11.2026
DOI: 10.1002/smll.76415 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 09.11.2026. Verfasst von Lucie Motyčková und 12 weiteren Autor:innen. Beteiligte Einrichtung: Max Planck Institute For Medical Research, Heidelberg, Germany. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Joachim Herz Foundation, Cluster of Excellence.
Abstract (Originalsprache)
The transport of therapeutics to their site of action is often hindered by biological barriers, such as cell layers and basement membranes. Among these, the inner limiting membrane (ILM) represents a major barrier within the eye, separating the vitreous body from the retina and restricting the penetration of intravitreally administered materials. Due to its dense, cross‐linked composition, only the smallest nanoparticles can pass through the ILM. Here, we demonstrate that active microcolloids decorated with enzymes can locally open the ILM and thereby facilitate the diffusion of passive carriers into retinal tissue. We utilize an ex‐vivo porcine eye model to determine the membrane permeability threshold using fluorescent nanoprobes. We further show that collagenase‐decorated silica microparticles can facilitate the transport of nanoparticles, while exhibiting excellent biocompatibility with no adverse morphological or functional retinal effects over a six‐week in vivo evaluation in a porcine model. Overall, our findings introduce a biocompatible and minimally invasive strategy to facilitate the targeted nanoparticle transport across biological barriers with promising implications for gene therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Max Planck Institute For Medical Research, Heidelberg, Germany.
- Institute For Molecular Systems Engineering and Advanced Materials, Heidelberg University, Heidelberg, Germany.
- University Eye Hospital Heidelberg, Heidelberg, Germany.
- David J Apple Laboratory For Vision Research, Heidelberg, Germany.
- Cryo Electron Microscopy, BioQuant, Heidelberg University and University Hospital, Heidelberg, Germany.
- Center For Nanomedicine, Institute For Basic Science, Seoul, Republic of Korea.
ORCID-Profile: Florian Peter, Niklas Junker, María I Real de Asúa Pérez-Serrano, Munisa Tabarova, Irene Wacker, Rasmus R Schröder, Maximilian Hammer, Dimitris Missirlis, Mariana Alarcón-Correa, Peer Fischer
Förderung
- Deutsche Forschungsgemeinschaft
- Joachim Herz Foundation
- Cluster of Excellence
- Bundesministerium für Bildung und Forschung
- Joachim Herz Stiftung
Zitieren
APA
Motyčková, L., Peter, F., Geisweid, L., Junker, N., Real de Asúa Pérez-Serrano, M. I., Tabarova, M., Curticean, R., Wacker, I., Schröder, R. R., Hammer, M., Missirlis, D., Alarcón-Correa, M., & Fischer, P. (2026). Enzyme‐Functionalized Microparticles to Open the Vitreoretinal Interface. Small. https://doi.org/10.1002/smll.76415
Vancouver
Motyčková L, Peter F, Geisweid L, Junker N, Real de Asúa Pérez-Serrano MI, Tabarova M, et al. Enzyme‐Functionalized Microparticles to Open the Vitreoretinal Interface. Small. 2026. doi:10.1002/smll.76415
BibTeX
@article{Motykov2026,
author = {Motyčková, Lucie and Peter, Florian and Geisweid, Ludwig and Junker, Niklas and Real de Asúa Pérez-Serrano, María I and Tabarova, Munisa and Curticean, Ronald and Wacker, Irene and Schröder, Rasmus R and Hammer, Maximilian and Missirlis, Dimitris and Alarcón-Correa, Mariana and Fischer, Peer},
title = {Enzyme‐Functionalized Microparticles to Open the Vitreoretinal Interface},
journal = {Small},
year = {2026},
doi = {10.1002/smll.76415}
}
EUVIMED